4.98
-0.09 (-1.68%)
| Penutupan Terdahulu | 5.06 |
| Buka | 5.15 |
| Jumlah Dagangan | 521,508 |
| Purata Dagangan (3B) | 1,515,398 |
| Modal Pasaran | 322,775,520 |
| Harga / Jualan (P/S) | 1.60 |
| Harga / Buku (P/B) | 8.83 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 5 May 2025 - 9 May 2025 |
| Margin Keuntungan | -57.69% |
| Margin Operasi (TTM) | -48.68% |
| EPS Cair (TTM) | -1.38 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 10.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 342.58% |
| Nisbah Semasa (MRQ) | 1.85 |
| Aliran Tunai Operasi (OCF TTM) | -31.00 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -17.44 M |
| Pulangan Atas Aset (ROA TTM) | -17.07% |
| Pulangan Atas Ekuiti (ROE TTM) | -148.19% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Bercampur | Bercampur |
| Diagnostics & Research (Global) | Bercampur | Bercampur | |
| Stok | Neuronetics, Inc. | Menaik | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -3.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -0.5 |
| Purata | 0.50 |
|
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 7.99% |
| % Dimiliki oleh Institusi | 48.99% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 8.00 (Canaccord Genuity, 60.80%) | Beli |
| Median | 7.50 (50.75%) | |
| Rendah | 7.00 (Citizens Capital Markets, 40.70%) | Beli |
| Purata | 7.50 (50.75%) | |
| Jumlah | 2 Beli | |
| Harga Purata @ Panggilan | 5.42 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Canaccord Genuity | 05 Mar 2025 | 8.00 (60.80%) | Beli | 5.42 |
| Citizens Capital Markets | 05 Mar 2025 | 7.00 (40.70%) | Beli | 5.42 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |